|
MRI News Service:
'DWI' p3 |
|
|
|
 |
 | | | ''Delivering on its Imaging 2.0 commitment to provide global access to leading edge imaging solutions, Royal Philips Electronics (NYSE: PHG, AEX: PHI) today showcased several new additions to its product portfolio, greatly expanding the offering to deliver ...' | | Wednesday, 30 November 2011 by www.prnewswire.com |
|
|
|
| | | ''Demonstrating the ability of Toshiba's VantageTM Titan MR system to help healthcare providers improve patient care and workflow in MR, Toshiba America Medical Systems, Inc., has installed the 1,100th Vantage MR system at Geisinger Health System in ...' | | | Tuesday, 1 November 2011 by medical.toshiba.com | |
|
|
|
| | | ''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced a national contract with Novation for ABLAVAR® (gadofosveset trisodium) and DEFINITY® Vial For (Perflutren Lipid Microsphere) Injectable Suspension, ...' | | | Friday, 21 January 2011 by www.businesswire.com | |
|
|
|
| | | ''Results from a large, worldwide, clinical trial show evidence that a first-of-its-kind pacemaker system is safe and effective to use during magnetic resonance imaging (MRI). During the trial, no MRI-related complications were reported in patients with ...' | | | Thursday, 6 January 2011 by www.healthcanal.com | |
|
|
|
| | | ''The mismatch between acute ischemic lesion visibility on diffusion-weighted magnetic resonance imaging (MRI) (DWI), and fluid-attenuated inversion recovery (FLAIR) MRI (DWI-FLAIR mismatch) can identify patients with acute ischemic lesions within 4.5 ...' | | | Wednesday, 5 January 2011 by www.doctorslounge.com | |
|
|
|
| | | ''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that on December 30, 2010 it commenced an exchange offer for eligible holders to exchange any and all of the company's outstanding unregistered 9.75% ...' | | | Friday, 31 December 2010 by www.radiopharm.com | |
|
|
|
| | | ''Molecular diagnostics provide precise information about a patient's cancer, and can help doctors decide on the best treatment. The rapid increase in the incidence of cancer worldwide, together with advances in specific cancer-focused biopharmaceuticals ...' | | | Friday, 22 October 2010 by newsroom.gehealthcare.com | |
|
|
|
| | | ''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR® (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent. ...' | | | Thursday, 14 October 2010 by www.radiopharm.com | |
|
|
|
| | | ''Bayer Schering Pharma announced the upcoming launch in China of Betaferon® (interferon beta-1b) for the treatment of relapsing-remitting forms of multiple sclerosis (MS). Betaferon is already approved in over 100 countries worldwide. With Betaferon and ...' | | | Saturday, 25 September 2010 by www.medicalnewstoday.com | |
|
|
|
| | | '' Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, supports the U.S. Food and Drug Administration's (FDA) announcement requiring safety-related label changes for all gadolinium-based contrast agents to highlight the rare ...' | | | Friday, 10 September 2010 by www.radiopharm.com | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
As far as the laws of mathematics refer to reality, they are not certain;
and as far as they are certain, they do not refer to reality.
- Albert Einstein |
|
|
News
top
